109 related articles for article (PubMed ID: 20508279)
1. Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT(3) receptor antagonist, in animal models of depression.
Devadoss T; Pandey DK; Mahesh R; Yadav SK
Pharmacol Rep; 2010; 62(2):245-57. PubMed ID: 20508279
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.
Pandey DK; Devadoss T; Modak N; Mahesh R
Indian J Med Res; 2016 Oct; 144(4):614-621. PubMed ID: 28256473
[TBL] [Abstract][Full Text] [Related]
3. Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
Bhatt S; Mahesh R; Devadoss T; Jindal A
Indian J Exp Biol; 2013 Jun; 51(6):435-43. PubMed ID: 23926691
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: an investigation in behaviour-based rodent models of depression.
Mahesh R; Kumar B; Jindal A; Bhatt S; Devadoss T; Pandey DK
Indian J Pharmacol; 2012; 44(5):560-5. PubMed ID: 23112413
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests.
Bhatt S; Mahesh R; Devadoss T; Jindal AK
Indian J Pharmacol; 2013; 45(4):348-53. PubMed ID: 24014909
[TBL] [Abstract][Full Text] [Related]
7. Anti-depressant-like activity of a novel serotonin type-3 (5-HT3) receptor antagonist in rodent models of depression.
Gupta D; Devadoss T; Bhatt S; Gautam B; Jindal A; Pandey D; Mahesh R
Indian J Exp Biol; 2011 Aug; 49(8):619-26. PubMed ID: 21870430
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT₃ receptor antagonist in behaviour based rodent models: evidence for the involvement of serotonergic system.
Gautam BK; Jindal A; Dhar AK; Mahesh R
Pharmacol Biochem Behav; 2013 Aug; 109():91-7. PubMed ID: 23680574
[TBL] [Abstract][Full Text] [Related]
9. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
Rajkumar R; Pandey DK; Mahesh R; Radha R
Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
[TBL] [Abstract][Full Text] [Related]
10. Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery.
Kurhe Y; Mahesh R; Gupta D; Thangaraj D
J Basic Clin Physiol Pharmacol; 2015 Jan; 26(1):25-33. PubMed ID: 24706431
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.
Kumar B; Jindal A; Pandey DK; Bhatt S; Devadoss T; Mahesh R
Indian J Exp Biol; 2012 Sep; 50(9):625-32. PubMed ID: 23140020
[TBL] [Abstract][Full Text] [Related]
13. Potential antidepressants: pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models.
Mahesh R; Rajkumar R; Minasri B; Venkatesha Perumal R
Pharmazie; 2007 Dec; 62(12):919-24. PubMed ID: 18214343
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
Bhatt S; Mahesh R; Devadoss T; Jindal A
J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):101-106. PubMed ID: 27664773
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
16. Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery.
Pandey DK; Rajkumar R; Mahesh R; Radha R
J Pharm Pharmacol; 2008 Dec; 60(12):1643-50. PubMed ID: 19000369
[TBL] [Abstract][Full Text] [Related]
17. QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: an approach based on behavioral and biochemical investigations.
Kurhe Y; Mahesh R; Gupta D; Devadoss T
Eur J Pharmacol; 2014 Oct; 740():611-8. PubMed ID: 24973694
[TBL] [Abstract][Full Text] [Related]
18. Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences.
Bhatt S; Mahesh R; Jindal A; Devadoss T
Pharmacol Rep; 2014 Oct; 66(5):804-10. PubMed ID: 25149984
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
Wang QS; Ding SL; Mao HP; Cui YL; Qi XJ
J Ethnopharmacol; 2013 Jul; 148(2):603-9. PubMed ID: 23702040
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
Freitas AE; Budni J; Lobato KR; Binfaré RW; Machado DG; Jacinto J; Veronezi PO; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):335-43. PubMed ID: 20026371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
